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Abstract 1 1 
 
Biotechnology, the Gene Revolution, and Proprietary Technology in Agriculture: 
A Strategic Note for the World Bank 
 
JH Dodds, R Ortiz, JH Crouch, V Mahalasksmi and KK Sharma 
 
John H Dodds Rodomiro Ortiz JH Crouch, V Mahalasksmi & KK Sharma 
Attorney-at-Law IITA ICRISAT 
1742 N Street c/o L.W. Lambourn & Co. Patancheru 
Washington DC 20036 26 Dingwall Road 502 324 Andhra Pradesh 
USA Croydon CR9 3EE, UK India 
j.dodds@doddsassociates.com R.Ortiz@cgiar.org  j.h.crouch@cgiar.org, v.mahalakshmi@cgiar.org 
   and k.sharma@cgiar.org   
 
The world economy experienced significant growth and transformation, with increases in productivity, 
product quality, and export base diversification in the 1990s. These advances were mainly driven by the 
growth of traditional agricultural and industrial sectors, including the natural resource-based sectors. 
This article outlines how application that New Science offers an opportunity for equitable growth that 
will assist in further poverty alleviation throughout the world. New Science will impact all poverty areas 
such as income, nutrition and environmental enhancement.  The principal objective of this document 
was to provide a textual report on the topic of innovation in science and technology, and in particular 
the way that new science such as biotechnology and information technology serve as factors for 
increasing the competitiveness of developing nations in the global context.  Interwoven into this subject 
matter the report provides clear positions to consider adopting in the critical areas of Intellectual Prop-
erty Rights, Biotechnology Biosafety, Trade and Environmental Protection.  The report addresses the 
following:  
• analyze the major advances and trends in the field of biotechnology. This includes both the animal 
science and commodity sectors. It focuses on a science-based approach to agricultural develop-
ment; 
• present an analysis of the policy framework in terms of Intellectual Property Rights (IPR) and Regu-
latory frameworks that underpin this research agenda; 
• review the current and potential legal liability issues that accompany the application of new science 
to research and development, including both health and environmental liabilities; 
• examine the current evolving IPR framework and the impact this may have on international national 
agricultural research in the developing world, especially regarding World Trade Organization (WTO) 
matters and Trade-Related Aspects of Intellectual Property Rights (TRIPS) as it relates to trade and 
research; 
• discuss the current and future trends in Public-Private partnerships and how these may play a role 
in enhancing technology development and availability; 
• scrutinize the current debate on genetically modified organisms (GMOs) and suggest a position on 
science and technology that underpins the risk assessment process; 
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• provide a preliminary analysis of the role of international development investors (e.g. The World 
Bank) in the development and deployment of International Public Goods; 
• describe briefly how innovations in this field are likely to affect the competitiveness and growth op-
portunities of countries in various stages of development, particularly on trade related matters; 
• illustrate succinctly how innovations in this field are likely to affect the competitiveness and growth 
opportunities, especially on international agricultural research; 
• characterize tools to develop international best practices in the fields of biotechnology and IPR 
management; and 
• draw conclusions to promote debate on the role of the public and private sectors in promoting inno-
vations in biotechnology as factors for increasing competitiveness of developing countries. 
This document also provides an assessment of the current impact of biotechnology and future potential 
to advancing agriculture, and the legal, environmental and economic implications, especially for the de-
veloping world. The document reviews the role of the private sector and how to strengthen its linkages 
with public, national and international research efforts. While addressing each of the selected topics, 
this document considers the evolution of research in agriculture, its accomplishments, and the potential 
role of biotechnology but not in isolation from other on-going research in agriculture. While reviewing 
the current status this article also considers how modern information technology or in other allied sci-
ences are reshaping the framework of future of agricultural research and what new targets are being 
pursued. The document looks at the future with a clear view of past experiences in research and tech-
nology and makes a candid assessment of what should be realistically expected from biotechnology ad-
vances.  
 
 
Summary of Recommendations 
Section 2. Biotechnology and Agriculture 
Further improvements in global agriculture require innovative science and the development of plant de-
rived products with high returns. Given that this type of research is based on a highly skilled workforce 
and the assembly of multidisciplinary teams: 
The World Bank should continue to build bridges between available biotechnology tools and their 
application for the improvement of crops and livestock in developing countries. Competitive funding 
schemes encouraging research links between advanced research institutes, both in the North and 
the South, and with the Consultative Group on International Agricultural Research should be pur-
sued.  
Furthermore, in order to have a research and development process driven by product delivery: 
The competitive funding scheme should ensure the integration of biotechnology with classical breed-
ing and other associated technical disciplines. The applicants must be encouraged to develop re-
search proposals in the framework of a holistic approach with well-defined pathways for disseminat-
ing both the knowledge and technology produced from this investment.  
 
Section 3. Biotechnology and Information Technology (or Bio-Informatics) 
Given that bioinformatics databases are International Public Goods that make possible these new tech-
nologies and products: 
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The World Bank should provide support for bioinformatics efforts that optimize resources, avoid du-
plication, and promote a new attitude of sharing in the scientific community.  
Given the current lack of technical skills in this area, particularly in the developing world: 
The World Bank should support personnel training. Trained people in bio-informatics are a pre-
requisite for this technology to succeed. Institutional links between North and South will not have 
an effect without skilled personnel in developing countries that can absorb, adapt, and use the in-
formation made available to them. 
In order to maintain public access and use of this data, particularly for the worlds staple food-crops that 
feed the poor: 
The World Bank should encourage and provide “seed money” to establish a public facility or consor-
tium for bio-informatics. This will require investments in human resources and computer equipment. 
A task force may be established, under the auspices of the World Bank, to develop an action plan 
for consolidation, centralization, and programmatic integration of bio-informatics teams working in 
this area. The CGIAR research centers should be a key part of this international public initiative.  
 
Section 4. IPR on Research and Agriculture 
Given the fundamental link between research investment and IPR: 
The World Bank should actively engage in debate and professional exchange with the World Intel-
lectual Property Organization (WIPO) to further study the impact of IP on research investment in 
the developing world. 
Given the need for more persons with technical and legal skills in these areas: 
The World Bank should foster more human resource development in the area of IP and particularly 
in entrepreneurship. The mix of technical and legal skills needed in the new economy is in short 
supply in developing countries. 
In order to develop a set of paradigm models, and to learn while doing: 
The World Bank should encourage well-researched, planned investment in global IP protection for 
inventions from developing countries.  
However, given that not all crops, animals, and technologies lend themselves to proprietary protection 
and market approaches: 
The World Bank can foster the development of International Public Goods for those technology plat-
forms or commodities where no proprietary avenues exist or are appropriate.  
 
Section 5. IPR and Trade 
Given the critical policy and development implications for the developing world: 
The World Bank should be a key player and actively advocate for the developing world in upcoming 
WTO discussions on trade and agricultural IP. 
Given the evolving nature of these complex relationships: 
The World Bank should continue to monitor the intimate relationship between trade, IP, and re-
search investment in both the public and private sectors. Research is indispensable for maintaining 
competitiveness in the market; accordingly, the World Bank should continue to foster and enhance 
its activities in agricultural research, including the CGIAR centers. 
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Section 6. Genetic Engineering Technology: A Complement to Breeding 
Because of concerns some sectors of the public have raised about genetic engineering technology:  
The World Bank should encourage and support public dialogue about the risks and benefits of trans-
genic technology used to improve agriculture in developing countries. This dialogue must ensure 
that the voices of the people in the developing world are heard and that their unique needs are con-
sidered.   
Furthermore, given the tremendous potential of these techniques to impact the quality of life for the 
poor: 
The World Bank should provide support to innovative improvement programs that combine the best 
of conventional methods with emerging genetic engineering technology to improve both crops and 
livestock. 
 
Section 7. Genetic Mapping Technology: Knowing Where the Genes Are 
The new tools of applied genomics are rapidly increasing our knowledge of biological systems and the 
tools to manipulate these systems. The commercial implications of these developments are fueling un-
precedented scientific progress but at the expense of free access.  
The World Bank should support initiatives in applied genomics to ensure that important advances 
will be made available to plant breeders in national programs and in small to medium-sized compa-
nies that are supporting the development of staple crops and livestock. As custodian of the world’s 
genetic resources, the CGIAR (Consultative Group on International Agricultural Research) interna-
tional system of agricultural research centers now has a major role to play in ensuring the equitable 
enhancement of the world’s staple food crops.  
 
Section 8. Molecular Breeding to Address Global Issues Such as Drought and Heat Stress 
The rapid development of molecular breeding tools for complex traits will require research projects that 
bring together large-scale multi-locational field experiments with state-of-the-art high throughput 
marker screening technologies and strong capacities in biometrics and bioinformatics. Hence: 
The World Bank should support long-term initiatives to undertake molecular breeding of crop and 
livestock species important to feeding the developing world. In this respect those CGIAR centers 
with breeding programs will continue to have a major role to play because they possess in-house 
capacity in all essential elements. 
 
Section 9. Changing Plant Architecture: New Plants for a New Future 
Given the need to feed more people on the same land area using less water and nutrients: 
Through a competitive grant framework the World Bank should encourage and support innovative 
research (including multidisciplinary approaches) aimed at the development of specific locally 
adapted prototypes to maximize the yield potential of crops. This investment could be cost-effective 
by tapping the knowledge and information accumulated by the CGIAR and their diverse partners. 
 
Section 10. Biosafety: How Safe are New Agricultural Technologies? 
Given that a number of other international organizations are already actively working with developing 
countries in the area of biosafety:  
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The World Bank should support the development of appropriate biosafety guidelines in the develop-
ing world by collaborating with other organizations engaged in similar efforts. 
 
Section 11. Food Safety: It Is Safe to Grow, but is It Safe to Eat? 
Given public concerns and the government’s fundamental role in setting food health policies: 
The World Bank should encourage and ensure science-based debate and decision-making about 
food health matters. The benefits of technological change, the possible risks of this change, and the 
consequences of no change should be addressed. 
 
Section 12. Bioethics 
Given the concerns associated with the development and deployment of genetically engineered organ-
isms: 
The World Bank (both management and staff) should be aware and sensitive to the issues 
surrounding GMO’s and other biotechnology applications. The World Bank should encourage 
scientific transparency; this will be the best tool to convince people about the advantages of 
transgenic crops and other biotechnology applications.  
 
Section 13. The Public Sector and International Public Good 
Given the tremendous opportunities that exist to leverage publicly available data: 
The World Bank should increase spending on infrastructure and human capacity building in regards 
to database management and information sorting and dissemination. 
Through support to the CGIAR, the World Bank can take steps to improve database management 
and ownership for many staple food commodities. The World Bank can foster a genome network for 
the developing world to access databases through the CGIAR and its partners. 
 
Section 14. Public Sector/Private Sector Partnerships: The Need for their Visionary  
Expansion and Diversity 
Given the globalization of agricultural research companies and the current shift in research resources 
from the public to the private sector: 
The World Bank should develop additional fora that will bring together the public and private sector 
in an enabling environment that will allow for the building of mutual trust and a dialogue on re-
search and regulatory issues. 
The World Bank should continue to support programs to enhance the skills of scientists, lawyers, 
and policy makers in these new areas of science and law. Skills in science and negotiation are im-
portant components for fair partnership arrangements. 
While proprietary technology will use market forces to drive license agreements in market economies 
and sectors, provision must be made for those sectors of society that are left behind. Therefore: 
The World Bank should try to identify areas where private sector proprietary technology developed 
for one purpose may be able to play humanitarian purposes in other areas, such as orphan crops or 
diseases prevalent in the developing world. 
 
Section 15. IPR and Animal Science 
Given the important economic and nutritional roles that livestock play in rural communities: 
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The World Bank should support special international studies to review the human health implications 
of genetically modified animal products. Given the costs associated with these studies, harmoniza-
tion and cross acceptance of data is very important. 
The World Bank should continue to study the impact of biotechnology and of quarantines on the 
trade of animal products. There is a special need to study these impacts as they relate to tropical 
diseases in Africa. 
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1. Introduction: Agriculture, Biotechnology, Poverty Alleviation, and             
International Public Goods 
A fifth of the world’s population lives in absolute poverty (less than US$ 1 per day), and almost 50% of 
the total world’s population lives on less than US$ 2 per day. Of this meager amount, 80% is spent on 
food. Extreme poverty and financial insolvency translate into despair and economic isolation, and it has 
been shown that food insecurity and poverty are significantly related with each other. Indeed, crises in 
public health and food production are distinctive features of Highly Indebted Poor Countries (HIPC). The 
statistics for these countries paint a grim picture. About 826 million people lack adequate food to eat, 
and 20% of the children in the world’s poorest countries do not reach the age of five. Furthermore, one 
third of all children under five in HIPCs are malnourished and physically stunted, which will negatively 
affect the rest of their lives. Their diets are often deficient in vitamins, leading not only to malnutrition 
but also to disease, and in severe cases, to blindness. It seems that these number of poor people may 
remain unchanged within the next decade if slow growth remains and inequality increases. However, 
the number of poor people may decline by 40% in 2008 if countries adopt policies and interventions 
fostering inclusion and benefiting all equally. Surely in the 21st century, when new agricultural technolo-
gies are readily available to enhance the nutritional value of crops and to increase their yields, the poor 
citizens of this planet have a right to benefit from these new technologies and to better their own lives 
and those of their children.  
Development investors and policy makers should act with all possible speed to bring modern science 
and technology to bear on the problems of public health, food insecurity, environmental degradation 
and demographic stress in HIPCs. Poverty reduction and economic development need a stable base of 
agricultural production, particularly since a high percentage of people in the developing world depend on 
agriculture for their livelihoods. In this regard, science-based agricultural improvements can play an 
important role. For example, recent developments and new breakthroughs in molecular and cell biology 
(often included under the umbrella of the word “biotechnology”) provide more and new sophisticated 
tools for the genetic betterment of crops, livestock, and fish, thereby improving yield potential—even 
under stress or in marginal environments—as well as the nutritional value of their food. Accordingly, it 
has become critical for development investors, such as the World Bank, to review advances made in 
applied agricultural biotechnology and to analyze how these advances can benefit the poor. 
An analysis of biotechnological crop improvement should take a holistic approach while recognizing at 
the same time the unique needs of HIPCs. It should consider the benefits to people working and living 
in the agro-ecosystem rather than just the plant species.  The key issue here is feeding a growing popu-
lation while protecting the environment.  Poor people must meet basic needs, and biotechnology has a 
roll to play here.  At the same time, it must be kept in mind that the poorest people in the developing 
world live in distinct agricultural and economic zones, face different health problems, and must over-
come agronomic constraints that are not the same as those in the northern hemisphere (39 out of 42 
HIPC are in tropical or desert (i.e., arid and semi-arid) environments and the other 3 in temperate 
zones). Futhermore, what is valuable biotechnology in the industrial world is not necessarily directly 
beneficial to the developing world, and vice-versa. This is one reason why biotechnology applications 
that benefit HIPCs have been only recently developed. A good example is vitamin A rice, or so-called 
“GoldenRice”. This rice is genetically engineered to produce vitamin A, which gives the rice grains a light 
gold color. In many areas of the world where rice is a basic staple, thousands of poor people every year 
lose their eyesight because of vitamin A deficiency. This new rice variety could deliver vitamin A directly 
to the poor in their staple food. Vitamin A deficiency is not a problem in the industrial world, but it is 
obviously of great benefit Asia’s rural poor. 
Agricultural biotechnology should not, however, be perceived as a panacea but as an important option 
for enhancing sustainable agricultural productivity and ensuring food security. Agri-biotech can reduce 
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poverty, especially in rural areas, where fragile environments can also be protected by the introduction 
of new eco-friendly technologies. In short, any strategy supported by development investors in regards 
to the deployment of agricultural biotechnology in the developing world must carefully determine how 
poverty issues will be addressed, keeping in mind that poverty alleviation requires an integrated solu-
tion because it is a multi-faceted problem.  
Of course, the use of agricultural biotechnology in the developing world carries its own multi-faceted 
problems, and it is the burden of this document to map them and chart a path forward. Most recent ad-
vances in agricultural biotechnology, for example, have been developed by the private sector, which has 
not been especially effective in explaining the benefits of these technologies to the public. Public per-
ceptions are affecting their adoption, especially in the industrialized world. A host of issues have arisen, 
all of which must be publicly addressed in both wealthy and poor countries, these include biosafety, 
food safety, and intellectual property rights, which govern not only the technology itself but also the 
methods through which it is invented and in some cases the living components of this technology.  
The debate about agricultural biotechnology in industrialized countries has made one thing very clear: 
the public’s voice must be heard and taken into consideration. Discussions need to be broadened to 
bring the public into the debate about the risks and benefits of using agricultural biotechnology to im-
prove food crops. While this is an issue that remains sensitive, especially for some of the inhabitants of 
the industrialized world, it is a debate in which the developing world must likewise have its own voice. 
Its right to set its own standards must be accepted. After all, developing counties have far different 
economies, ecologies, and climates than those of northern nations. They must ensure that the new sci-
ence serves their needs and aspirations.  
A more proactive approach than the one taken so far by the private sector is needed to ensure equita-
ble access to proprietary agricultural biotechnology tools. Only then will the benefits of the so called 
‘gene revolution’ reach the poor, particularly in rural areas of the developing world. Furthermore, agri-
cultural biotechnology products developed by the private sector must, of course, be deployed in a way 
that considers both environmental issues and human health.  
Indeed, without the establishment and effective enforcement of acceptable principles for human and 
ecological safety, deals between the public and private sector cannot be brokered. As a first step, de-
velopment investors, national agricultural research systems, private seed and agricultural biotechnology 
companies, as well as non-governmental organizations (NGOs) and other institutions in civil society 
must strive to better understand their respective agendas, especially in the framework of globalization. 
Such an exchange between the key players in agricultural development will help to determine whether 
they can work together—and perhaps even collaborate (e.g., a multi-partner venture)—to share innova-
tive technology and resources that can be harnessed to develop public goods for the benefit of the poor 
in this era of globalization. Globalization is the future, and quixotic attempts to derail it will harm the 
world’s poor more than any other group. Instead, we must carefully weigh its benefits and costs in the 
light of a more just, humane, and equitable vision of the future. If properly guided, globalization—under 
the on-going scrutiny of the public—could provide access to markets, capital, technology, and tech-
niques that would assist the efforts of the developing world to achieve sustainable food security and to 
establish an economic base for further growth.  
The massive increase in rice and wheat production spearheaded by the centers of the Consultative 
Group on International Agricultural Research (CGIAR)—the so-called “Green Revolution”—is one of the 
best examples of the use of genetic resources and conventional plant breeding to improve cereal crops 
(especially rice and wheat). Farmers widely adapted and adopted these varieties, increasing the aggre-
gate food supply through productivity gains in agriculture, which made it possible for developing coun-
tries to avoid the specter of poverty: hunger. Thanks to the Green Revolution, especially in Asia and 
Latin America, by conservative estimates the lives of 400 million people were saved. That said, we can-
not continue to rely on the “Green Revolution” for further productivity and income gains. We must ac-
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cept that almost all-usable agricultural land is now under cultivation. Indeed, any significant increase in 
production must come through increased productivity on the same land area. Furthermore, the vast 
majority of new agricultural technologies are proprietary and cannot be easily distributed by national 
agricultural research centers. 
The value of these new technologies, however, is much greater than those of the “Green Revolution.” 
By incorporating resistance to pests into crops, for example, crop and yield quality improves without the 
high costs and environmental problems associated with pesticides. The profits of poor farmers are en-
hanced through eco-friendly technologies that can provide sustainable food security in HIPCs. In addi-
tion, high yielding crops provide job employments to poor people through the trade chain (from har-
vesting to processing). In short, higher and more stable yield potential and profitability permit poor 
farmers to invest in inputs to produce more food and income. This may in turn lead to reduced food 
prices for the urban and rural poor. Furthermore, enhanced productivity makes more food accessible 
and available for sale, and other crops may be included in the farming system, thereby increasing agro-
biodiversity. 
The World Bank and other development investors need to ensure that agricultural biotechnology will 
improve the livelihoods of the poor. They can do this by providing targeted support and especially by 
brokering agreements with the private sector, which owns most of the science. For rural areas of Africa 
and other locations by-passed by the “Green Revolution”, such investments and agreements are crucial. 
The worlds’ poor, who stand to benefit most from new agricultural technologies, cannot afford to miss 
the benefits of the “Gene Revolution.” Yet for agricultural biotechnology to benefit the poor farmers and 
consumers of the developing world, it will need to focus on their problems and needs. Investments in 
agricultural biotechnology in developing countries, however, must be built upon those already made by 
the private sector. These countries do not have the resources to re-invent the technologies made possi-
ble by billions of dollars worth of research and development by the private sector. Creative partnerships 
are essential to success. Moreover, technology and genetic resources are only part of the solution—they 
will not alleviate poverty by themselves. Cooperation between the rich and poor nations of the world, 
institutional alliances, information and knowledge sharing, and the development of intellectual property 
rights management systems should all be part of integrated technology transfer packages for the bene-
fit of the poor. Clearly, innovative partnerships are needed to provide long term and sustainable financ-
ing for producing the international public goods that will enhance the livelihood and prosperity of to-
day’s poor in HIPCs. 
The World Bank should lead efforts to ensure that investments in agricultural biotechnology produce 
international public goods that benefit the world’s poor. To this end, it should facilitate innovative ar-
rangements with the owners of proprietary science and technology. To be effective, such arrangements 
must be flexible, efficient, and inclusive. They must respond coherently to the needs of the poor, espe-
cially in the rural developing world. The World Bank’s institutional centrality gives it a unique position—
and responsibility—to open high-level policy dialogues with all relevant parties. This approach will be 
very important because the World Bank’s own investments are insufficient to meet the agricultural re-
search needs of the developing world. Indeed, neither the World Bank nor developing countries should 
waste limited funds and precious time in re-inventing technologies developed and owned by the private 
sector. Partnerships are the solution, and by facilitating such international coordination, the World Bank 
will have taken a major forward step towards global equity. 
Consider the possibilities of a Global Development Agenda that links up public and private investments 
in agricultural biotechnology to alleviate poverty. Improvements to the “orphan” crops of the world’s 
subsistence farmers, such as chickpea, pigeon pea, sweet potato, cassava, yam, plantain, cowpea, and 
lentil, which the private sector has not included in its investment portfolio, will dramatically improve 
these farmers’ lives. Their crops could benefit either from the transfer of agricultural biotechnology 
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methods for their improvement (e.g., gene transfer through transgenics), or from knowledge obtained 
by researching a better-endowed crop that may be relevant for enhancing these “orphan” crops.  
Let us now proceed to review the various critical components of this new science and the new policy 
environments that accompany them, and indicate what decisions are needed in each area in order to 
bring about an integrated science and policy framework that will bring the benefits of these new tech-
nologies to the world’s poor farmers. 
 
 
2. Biotechnology and Agriculture 
2.1 Background and Prior Debate 
In the last century, genetics became a key scientific discipline. Revolutionary discoveries rapidly fol-
lowed one another: the identification of DNA  as hereditary material, the elucidation of the double helix 
structure of the DNA molecule, the cracking of the genetic code, the ability to isolate genes, and the 
application of DNA recombinant techniques. These advances also shaped animal and plant breeding, 
whose respective methods changed dramatically throughout the 20th century. Today we understand the 
molecular basis of genetics, and new tools allow us to exploit that knowledge in very specific ways for 
crop and livestock improvement. 
Scientific advances in plant breeding led to the “Green Revolution”, regarded as one of the most impor-
tant agricultural achievements of mankind. This Revolution targeted staple cereal crops, particularly 
wheat, rice, and maize, with staggering results. Towards the end of the 20th century 370 kg of cereals 
per person were harvested versus 275 kg in the mid-20th century—more than a 33% per capita gain. 
Other crops have made gains of about 20% since the early 1960s. In simple terms, this prevented the 
starvation and malnutrition of almost 1 billion people. However, the “Green Revolution” appears to have 
been fully maximized, and other approaches are needed to continue to improve plants and livestock in 
the 21st century. The need is increasingly urgent because the per capita area to support food production 
will decline from 0.44 ha in 1961 to 0.15 in 2050. Again, in simple language, our growing population 
requires increased agricultural productivity to stave off mass famine outbreaks in the developing world.  
Biotechnology complements classical breeding tools with new and better means to improve both crops 
and livestock. Most of the staple foods of the poor, which feed millions of people daily, have received 
little attention from the biotechnology industry because they are not regarded as cash commodities. 
Applying biotechnology in animal and plant breeding is nowhere more essential, however, because of 
the pressing challenge of providing food to the more than 1 billion hungry people in the developing 
world, more than 185 million of which are malnourished school children. Biotechnology offers new 
means to achieve a higher intensity of selection (e.g., through in vitro techniques) and more objective 
selection methods through genetic markers. Likewise, genetic engineering(so-called transgenic) can 
insert new genes into plants to enhance the quality of a new variety and enlarge the breeding pool. In 
what follows we offer some examples of the new biotechnology and indicate some of the value these 
new products have for the developing world.  
 
2.2 Identification of Key Issues 
The most common and successful application of biotechnology for crop and livestock improvements are 
in: 
• Cell and Tissue Culture is a process of growing plant cells to produce uniform individuals or to 
shorten the number of years needed to produce and release new varieties. Tissue culture tech-
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niques have led to dramatic production increases in cassava, yams, bananas and plantains, palms, 
and potato to mention only a few. Tissue culture laboratories also employ highly skilled staff, mainly 
in the private sector in the developing world. 
• Genetic Engineering for pest and disease resistance. There are now hundreds of millions of 
acres of genetically engineered crops grown throughout the industrial and developing world. To date 
the principal focus has been on crops that use large amounts of pesticides or herbicides, such as 
maize, cotton, potatoes, and soybeans. 
• DNA fingerprinting, the same technology used in forensic science, provides better insights into 
pathogen diversity, which may make it possible to prevent the breakdown of host plant resistance 
to pests and diseases. Sources of genetic diversity are the building blocks from which new breeds 
and varieties are developed, and DNA fingerprinting makes it possible to use this diversity more ef-
fectively. 
• Molecular-aided analyses can lead to better management of seed storage facilities, or so-called 
gene banks, and to greater knowledge of biodiversity. The more we know about this genetic diver-
sity, the better we can apply it to produce higher yielding, more resistant materials. 
• DNA markers allows scientists to locate genes with specific disease and pest tolerance. We may 
eventually be able to study resistance to more complex traits such as drought and heat stress. We 
have already witnessed what the human genome-sequencing program is starting to achieve, and we 
must apply the same tools to improve agriculture. 
• New testing tools to detect pests, diseases, and dangerous food contaminants. These techniques 
will help us produce not only more food, but food that is more nutritious and safer to eat. 
 
2.3 Future Trends 
The speed of research in these fields is dramatic. The commercial company Celera-Genomics was able 
to sequence the entire human genome in less than one year. Within the next decade, research in crop 
improvement will target: 
• Male sterility systems to allow genetic engineering for hybrid seed production, with its dramatic 
yield increases, in currently self-pollinating crops. 
• Short-cycling populations for rapid improvement of forest and fruit trees. 
• Converting annual into perennial crops for more sustainable agricultural systems. 
• Farming in environmentally friendly systems with pest and disease resistant germplasm. 
• Enhancing adaptation to environments affected by problems such as drought, salinity, extreme 
temperature, chemical toxicity and oxidative stress. Given future projections on global climate 
change, these long-term goals are vital to the developing world. 
• Improvement of food quality (e.g., vitamin A content), to satisfy the needs for a balanced diet in 
poor rural areas as well as for new demands for varied diets in urban populations with more income. 
GoldenRice is a good start in this area. Research groups are already attempting to further improve 
GoldenRice by enhancing the quality of the rice protein to contain more essential amino acids. 
• Improved plants and animals to fit into intensive peri-urban agriculture systems, which require spe-
cific plant architecture, tolerance to urban pollution, efficient nutrient uptake, and crop acclimatiza-
tion.  
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2.4 Major Constraints and Opportunities 
Biotechnology will be an important tool to ensure success in the above areas. In addition, biotechnology 
may also provide new methods to add value to raw agricultural products (e.g., growing edible portions 
of food crops in vitro or converting plants into producers of high value chemicals). “Pharming” (derived 
from Pharmaceutical) is the term that has been coined to refer to a new system in which medicine pro-
duction capabilities are incorporated into a plant. A research group at The Boyce Thomson Institute at 
Cornell University has already engineered banana plants to produce vaccines 
The new tools of molecular genetics enable researchers to understand better and faster the full potential 
of the genetic resources of crops, to preserve this genetic heritage, and to develop improved plant ma-
terials. The identification, isolation, and cloning of new genes controlling specific characteristics will also 
facilitate the development of a more stable, diversified germplasm with improved resistance to diseases 
and pests, stress tolerance, better food quality, and higher productivity. For example, genes allowing a 
reduced crop cycle or modified plant structure will provide pathways for new cropping systems. None-
theless, conventional crossbreeding will be still required for appropriate testing and further transfer of 
these genes to the advanced breeding pools of the crop. Furthermore, seed delivery systems of im-
proved genotypes will need to be in place to promote the utilization of new cultivars, which will enhance 
and stabilize agricultural production, farm income, and farm-family welfare. In brief, the new tools of 
biotechnology alone cannot provide the answer to genetic improvement, but they are facilitating and 
accelerating the pace of the development of new cultivars. 
Some of the current achievements of biotechnology applications for improving agriculture are surpass-
ing original expectations, and the outlook appears to be even more promising. The fulfillment and im-
pact of biotechnology, however, does not depend only on the demonstrated research advances and 
technology ensuing from their applications but also on both favorable regulatory frameworks by national 
governments (or through regional agreements) and positive public acceptance.  
 
2.5 Recommendations 
Further improvements in global agriculture require innovative science and the development of plant de-
rived products with high returns. Given that this type of research is based on a highly skilled workforce 
and the assembly of multidisciplinary teams: 
The World Bank should continue to build bridges between available biotechnology tools and 
their application for the improvement of crops and livestock in developing countries. Com-
petitive funding schemes encouraging research links between advanced research institutes, 
both in the North and the South, and with the Consultative Group on International Agricul-
tural Research should be pursued.  
 
Furthermore, in order to have a research and development process driven by product delivery: 
The competitive funding scheme should ensure the integration of biotechnology with classi-
cal breeding and other associated technical disciplines. The applicants must be encouraged 
to develop research proposals in the framework of a holistic approach with well-defined 
pathways for disseminating both the knowledge and technology produced from this invest-
ment.  
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3. Biotechnology and Information Technology (or Bio-Informatics) 
3.1 Background and Prior Debate 
A relatively new field, bio-informatics is the scientific management and use of genetic information. In 
large laboratories sequencing and genetic mapping has led to massive databases of different types of 
genetic information. This data is valuable and can lead to further discoveries—but only if it is carefully 
managed. Indeed, the enormous amount of information to be tracked has made the computer an indis-
pensable tool for genetic research. In fact, the breathtaking research speed of the human genome pro-
ject would not have been possible if Celera Genomics had not built the largest non-military super com-
puter in the world.  
‘Genomics’ refers to the systematic use of genome information, in conjunction with new experimental 
data, to answer biological questions. The success or failure of genomic projects now depends on the 
availability and utility of their data to the scientific community. The best example of this is the “Human 
Genome Project.” Conceived in the mid-1980s, sequencing of the human genome began in 1996 and 
was completed in early 2000, years ahead of the scheduled completion date. One reason for the speedy 
completion of this effort: large investments by the private sector, which had identified the Project’s po-
tential utility. These investments produced a number of technical innovations that greatly contributed to 
the success of the Human Genome Project. The sequencing and mapping components of the project, for 
example, relied heavily on advances made in the automation and robotics of the sequencer, allowing for 
the production of sequence data at an extraordinary rate. This in turn generated advances in informa-
tion technology that led to the genesis of ‘bio-informatics’—otherwise the Project would have “drowned 
in data.”  
Currently bioinformatics provides procedures for identifying, protecting, and sharing critical research 
information. Indeed, access to sequenced data is critical for continued advances. A major stimulus to 
new work in bioinformatics was the widespread availability of the Internet in the mid 1990s. The World 
Wide Web made it much easier to share and integrate databases, distribute software, and perform so-
phisticated analyses. Currently, there are at least 400 internet-accessible databases of biological infor-
mation and about 20 software applications to analyze sequence data. This knowledge-based revolution 
can drive agricultural research for the benefit of all. 
International efforts to create a plant-crop genome project similar to the Human Genome Project are 
already producing results. Japan,for example, is leading the International Rice Genome Sequencing Pro-
ject (IRGP). Recently, Monsanto Company also agreed to share its rice genome data with researchers 
across the world. Developing countries are aware of these efforts and some of them have already in-
vested in plant genomics. 
 
3.2 Identification of Key Issues 
Advances in genomics will require sharing databases. No one will succeed alone. Accordingly, interna-
tional cooperation is essential. Current databases are already enormous and complex, and new informa-
tion is constantly being added. Successful data mining and pattern determination—the first steps to di-
agnostics and/or remedies—will only be possible if acceptable structures and guidelines for database 
sharing are developed. This raises the following key issues: 
• Users must recognize the need to share information  
• Access to information must be obtainable, especially for countries that lack advance information 
infrastructures  
• Investments in information and communication technologies to promote sharing and access to in-
formation must continue 
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3.3 Future Trends 
Bioinformatics is a new way to handle genetic data and develop new products. There will be more and 
more sharing of data and information through the Internet, although this will raise concerns about the 
authenticity of such information. To ensure fairness and credibility a new code of ethics may have to be 
put in place. Furthermore, as we discuss later, this technology opens the door to the development of 
artificial chromosomes and to their accompanying ethical issues. 
 
3.4 Major Constraints and Opportunities 
The two major constraints to the effective use of these new technologies in developing countries are 
lack of access to the necessary information and lack of trained personnel to use it. Currently, the Infor-
mation Technology industry is investing heavily into bio-informatics; both IBM and Compaq have re-
cently invested hundreds of millions of dollars in bioinformatics ventures. The next step in bioinformat-
ics will be to put the information it has generated to use in practical applications (e.g., using data ob-
tained from genomics and bioinfomatics to develop diagnostics or therapies).  
 
3.5 Recommendations 
Given that bioinformatics databases are International Public Goods that make possible these new tech-
nologies and products: 
The World Bank should provide support for bioinformatics efforts that optimize resources, 
avoid duplication, and promote a new attitude of sharing in the scientific community.  
 
Given the current lack of technical skills in this area, particularly in the developing world: 
The World Bank should support personnel training. Trained people in bio-informatics are a 
pre-requisite for this technology to succeed. Institutional links between North and South will 
not have an effect without skilled personnel in developing countries that can absorb, adapt, 
and use the information made available to them. 
 
In order to maintain public access and use of this data, particularly for the worlds staple food-crops that 
feed the poor: 
The World Bank should encourage and provide “seed money” to establish a public facility or 
consortium for bio-informatics. This will require investments in human resources and com-
puter equipment. A task force may be established, under the auspices of the World Bank, to 
develop an action plan for consolidation, centralization, and programmatic integration of bio-
informatics teams working in this area. The CGIAR research centers should be a key part of 
this international public initiative.  
 
 
4.  IPR on Research and Agriculture 
4.1 Background and Prior Debate 
Most legislation worldwide regards it reasonable for an inventor to have the right to exclude others from 
the sale or use of an invention for a limited time in return for a full public disclosure of how the inven-
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tion is performed. On the one hand, this right of exclusivity allows the inventor to recuperate his re-
search investments by not allowing his competitors to use his intellectual property for free. On the other 
hand, the public disclosure of the invention allows competitors to improve upon or work around the pat-
ent. 
It has been clearly demonstrated that intellectual property (IP) protection has served to foster research 
and development. A frequently cited example of the power of IP protection to stimulate research in-
vestment and innovation is biotechnology. The landmark United States Supreme Court decision in Chak-
rabharty allowing patents on living organisms resulted in huge investments in biotechnology because 
companies could realistically expect to recuperate their investments.   
This investment boom in biotechnology and information science continued throughout the 1990’s and 
into the new millennium. The US Patent & Trademark Office now has more patents pending than it has 
issued in its entire 200+year history, and most of these are in the fields of biotechnology and informa-
tion technology. 
Another fundamental component to IP protection and research is the so-called “research exemption”. 
This statutory provision provides for a person to use a patented invention where the intention is to use 
the patented technology for further research.  This exemption is important as it permits "academic" re-
searchers to add to the body of knowledge.  Care should be exercised in the use of this exception as it 
is viewed narrowly and only relates to 'academia' not 'applied' research. 
One of the challenges that public research organizations worldwide face is to determine whether they 
should seek proprietary protection of their research in order to obtain funds or recoup costs. In the 
United States, the Bayh/Dole Act (1980) allows public research organizations to hold the title to their 
inventions if invented using Federal research dollars. Although this can potentially serve as a source of 
funding for public institutions,  also blurs the lines of comparative advantage between the public and 
private sectors 
 
4.2 Identification of Key Issues 
One key issue is to determine whether agricultural research is in some way “special” as it relates to IP 
and research. After all, human well being depends on food, the enhanced production of which will de-
pend on the timeframes of research processes and on free global access to genetic resources. As such, 
agricultural research may deserve “special” status.  
Some of the critical questions in this area that policy makers at the international, national and institu-
tional levels need to address are given below. We also offer our viewpoint as to the answers to these 
questions: 
1. Does IP protection truly stimulate research investment in agriculture? We believe the answer is 
clearly yes. Since the ruling of the US Supreme Court allowed for patent protection on living organ-
isms there has been a massive investment in life sciences research. Billions of private sector dollars 
have been invested in biotechnology applications for health, food and environmental remediation. 
2. Can proprietary research help fund developing country research? Again, our viewpoint is yes. There 
is no reason to believe that innovative research is less valuable because of geography. The growth 
of the software development industry in India and other parts of Asia is a good example. Several 
multinational seed companies are already investing heavily in new research infrastructure in the de-
veloping world. More can and should be done. 
3. Should governments or institutions see this as a revenue source or only as cost recovery? The mini-
mum here is cost recovery, but as with not-for-profit research foundations in the industrial world, 
any “profit” could be reinvested into these organizations to further the development of more 
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research output. Egypt’s Agricultural Genetic Engineering Research Institute (AGERI) has set up a 
foundation that funnels the benefits of its license agreements with Pioneer back into more research. 
4. Is there a role for truly “public” goods, both nationally and internationally? Clearly Yes. Producing 
animals and plants with resistance to certain pests and diseases, scourges that pay no heed to na-
tional boundaries, is a regional or international public good. Enhanced nutrition to alleviate human 
diseases associated with poverty is an international public good, and breeding for resistance to cli-
mate variation is also an international public good. 
5. Does publishing play a key role in the public domain? Clearly Yes. If an organization wishes all its 
research output to be public goods then it should publish. Published research is so-called “prior art” 
and will serve to bar others from claiming such invention.  The published article identifies the "in-
ventor" and serves as a defensive publication.  No one can now patent the invention as they are not 
the inventor and the publication identifies the true inventor. 
 
4.3 Future Trends 
Modern research is increasingly complex and involves significant interdisciplinary activities. These inter-
actions across a range of disciplines will continue to grow and expand, thus adding to the complexity 
and cost of research. 
The present growth of proprietary science will continue to grow because of the private sector’s massive 
research investments. Projects such as the Human Genome Project will spawn new related ventures in a 
variety of areas. Celera Genomics, the company that first completed the human genome sequence, is 
already building the world’s largest protein sequencing and engineering facility. 
The globalization of research will continue, and the developing world will perform more of it because of 
a range of comparative advantages. What has already begun in the software industry will continue to 
develop in environmental science and agriculture. This growth will be coupled with increasing changes in 
the globalization of IP laws and the relationships of trade in a global economy. 
 
4.4 Major Constraints and Opportunities 
Constraints: 
There is the potential for a backlash against IP protection in the area of living organisms and in food 
production. If it occurs, negative public perceptions of the technology will be the reason. These may be 
due to fundamental ethical or religious beliefs, or because of misunderstandings about the nature of the 
technology. 
The drive to produce global technologies for a global market, with all the associated regulatory frame-
works, may also push small companies, if not countries, out of the market. The IP portfolio of the small 
will be eaten by the big. Some even doubt that current anti-trust laws can adequately deal with these 
problems. 
 
Opportunities: 
There are opportunities to harmonize and simplify the current IP system to level the playing field for the 
smaller entities that wish to seek global protection. IP statutes could be amended to more equitably re-
ward invention, including those who work through non-conventional channels. 
When good quality science is performed in the public sector and when adequate and effective protection 
is established, budget allocations for public research can be increased. More efficiency and more 
creativity are already appearing, and the public sector can use IP tools to generate new revenue for 
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tivity are already appearing, and the public sector can use IP tools to generate new revenue for more 
investment in research. 
 
4.5 Recommendations 
Given the fundamental link between research investment and IPR: 
The World Bank should actively engage in debate and professional exchange with the World 
Intellectual Property Organization (WIPO) to further study the impact of IP on research in-
vestment in the developing world. 
 
Given the need for more persons with technical and legal skills in these areas: 
The World Bank should foster more human resource development in the area of IP and par-
ticularly in entrepreneurship. The mix of technical and legal skills needed in the new econ-
omy is in short supply in developing countries. 
 
In order to develop a set of paradigm models, and to learn while doing: 
The World Bank should encourage well-researched, planned investment in global IP protec-
tion for inventions from developing countries.  
  
However, given that not all crops, animals, and technologies lend themselves to proprietary protection 
and market approaches: 
The World Bank can foster the development of International Public Goods for those technol-
ogy platforms or commodities where no proprietary avenues exist or are appropriate.  
 
 
5. IPR and Trade 
5.1 Background and Prior Debate 
The spectacular bull run of the U.S. stock market and the globalization of trade dominated economic 
changes over the last two decades. Heated debates, sometimes literally bursting into flames, have fu-
eled the development of regional and international trade pacts. We have seen the growth of trade-
related legislation and organizing bodies such as the Asia Pacific Economic Community (APEC) and the 
North America Free Trade Association  (NAFTA). We also witnessed the formation of the World Trade 
Organization (WTO) as a forum for reaching agreements about these matters. 
As part of the globalization of the world economy and the massive increase in global trade, rules and 
regulations relating to intellectual property have been developed. The so-called TRIPS [Trade-Related 
Aspects of Intellectual Property Rigths (General Agreement on Tariff and Trade -(GATT/WTO)] provi-
sions have brought IP protection front and center in trade matters. 
In many cases, trade related IP matters involve agricultural products. In some cases arguments have 
even broken out between nations who hardly even produce the materials ( e.g., the banana wars be-
tween the USA and Europe). 
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The formation of a global trading system and regional trading pacts has transformed what were previ-
ously national jurisdictional IP issues into international issues. IP has become a global, trade related 
practice through international conventions that regulate its use, and the lines that clearly demarcated 
patents as national rights have been substantially blurred in recent years. 
 
5.2 Identification of Key Issues 
IP protection is still in the process of being formalized, and the upcoming rounds of debate at the WTO 
on Agriculture will keep it in the policy spotlight. A number of critical issues face policy makers in com-
ing years, including: 
1. WTO Agriculture Round Negotiations. 
2. Continued Globalization of Agricultural Trade. 
3. The issue of non-tariff IP matters, such as the release of genetically modified foods or organisms 
(GMOs). 
4. Globalization of IP protection and concurrent transactional costs. 
 
5.3 Future Trends 
Despite protests from some sectors of the public, more trade pacts and global alliances are in the pipe-
line. Many of them seek to distinguish between governmental trade pacts and the globalization of the 
private sector. There are also discussions of how a global regulatory framework, such as a global SEC, 
could review the antitrust potential of international mergers and acquisitions. The non-tariff elements of 
trade will continue to grow in coming years, both on good and bad faith grounds, and the new electronic 
economy will also likely have a very dramatic and somewhat unpredictable impact on the global trade of 
commodities, goods, and services. 
 
5.4 Major Constraints and Opportunities 
Constraints: 
Both policy makers and the general public lack information about the pros and cons of IP and trade 
matters. This knowledge deficit allows special interest groups to take the limelight and spread their own 
“message” without accountability. A balanced, well-informed, and transparent debate is urgently 
needed. 
The existing system also has to deal with an unprecedented rate of change. Current regulatory struc-
tures and existing national legislation are often unable to deal with the speed and nature of ongoing 
trade related changes. Furthermore, global litigation of trade matters, although necessary in the current 
framework, is slow and costly and therefore favors big entities over small ones. More efficient mecha-
nisms for resolving disputes must be devised. 
 
Opportunities: 
New technologies and new trading relationships offer tremendous opportunities for new growth, espe-
cially the rapid expansion of markets to developing countries. 
Global trade allows each country and entity to more effectively focus on its comparative advantages and 
thus maximize return on investments or research. 
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New markets create greater diversification and increased output, generating more and better employ-
ment opportunities. Opening markets creates internal competitive pressures that in a positive environ-
ment can be translated into increased efficiency and higher productivity. 
 
5.5 Recommendations 
Given the critical policy and development implications for the developing world: 
The World Bank should be a key player and actively advocate for the developing world in up-
coming WTO discussions on trade and agricultural IP. 
 
Given the evolving nature of these complex relationships: 
The World Bank should continue to monitor the intimate relationship between trade, IP, and 
research investment in both the public and private sectors. Research is indispensable for 
maintaining competitiveness in the market; accordingly, the World Bank should continue to 
foster and enhance its activities in agricultural research, including the CGIAR centers. 
 
 
6. Genetic Engineering Technology: A Complement to Breeding 
6.1 Background and Prior Debate 
Conventional plant breeding and improved agricultural practices produced impressive gains in crop pro-
ductivity in the 20th century. But human and livestock population pressures continue to increase, and 
conventional plant breeding can no longer deliver significant gains in productivity because of limited 
gene pools and the restricted range of organisms between which genes can be transferred. There is also 
limited scope for increasing the amount of land available to cultivate food crops without seriously im-
pacting the environment. New techniques that supplement conventional plant breeding are needed to 
boost crop yields, particularly for staple food crops in developing countries. Genetic transformation, a 
form of genetic engineering, now provides a complementary means to enhance field crops. Genes can 
be accessed from exotic sources—plant, animal, bacteria, and even viruses—and introduced into crops.  
 
6.2  Identification of Key Issues 
Over the past two decades, scientists have made significant progress in introducing foreign genes into 
plants, and this has made it possible to modify crops to increase yields, impart resistance to biotic and 
abiotic stresses, and improve nutritional quality. Among the examples of this are vitamin A rice, pest 
resistant maize, cotton, and potato, and a wide range of plants resistant to virus diseases. Millions of 
acres of these genetically engineered crops are now grown throughout the world. The flow diagram pre-
sented in Figure 1 describes how transgenic technology has been integrated into conventional plant 
breeding to enhance crop plants.  
 
6.3 Future Trends 
1. Modern agricultural biotechnology is one of the most promising developments in modern science, 
and research in agricultural biotechnology the potential to make major impacts on rural poverty. 
Eventually, improving agriculture through biotechnology could generate social, economic, and envi-
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ronmental benefits targeted at specific needs, especially the needs of the poorest. Again, the ability 
to produce more nutritious crops, or crops that need less fertilizer and water are good examples. 
2. The indisputable core issue is the need to mobilize every instrument of agricultural transformation 
in our efforts to feed the hungry, help the poor, and protect the environment. 
3. Regulations need to be harmonized and regulatory mechanisms simplified in the future. Much pro-
gress has been made in this area in the protocol talks under the Convention on Biological Diversity. 
4. Agricultural biotechnology research must produce applications that are relevant to the needs of 
farmers in developing countries, and the benefits of that research must be transmitted to small-
scale farmers and consumers in those countries at affordable prices. Yet again vitamin A rice is a 
good example. Other ongoing work on protein enhancement technologies and other nutritional en-
hancements is of vital importance to the world’s hungriest. 
 
Figure 1: The Integration of Transformation Technology with Plant Breeding 
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6.4 Major Constraints and Opportunities 
Despite significant advances over the past decade, the lack of efficient transformation methods can still 
be a substantial barrier to applying recombinant technologies in some crop plants. For successful ge-
netic transformation in the routine generation of transgenic plants, several key factors play important 
roles. These include the development of reliable tissue culture and plant regeneration systems, prepara-
tion of gene constructs and transformation with suitable vectors, efficient transformation techniques for 
the introduction of genes into the crop plants, recovery and multiplication of transgenic plants, molecu-
lar and genetic characterization of transgenic plants for stable and efficient gene expression, transfer of 
genes into elite cultivars by conventional plant breeding methods if required, and evaluation of trans-
genic plants for their effectiveness in alleviating biotic and abiotic stresses without causing environ-
mental risks. A major limitation to the practical transformation of many plant species is the low fre-
quency of tissue culture regeneration, which leads to very low genetic transformation success rates. 
These technologies are now well established in the North, and in the developing world the focus is turn-
ing to studies that will apply these powerful tools to solve national and regional needs. In the human 
health area, many diseases that are unique to the developing world can be addressed through these 
techniques. Celera has already projected that a malaria vaccine will be available within two years. The 
ability to produce plants that are more productive in marginal lands where water and often nutrients are 
scarce will also have a huge impact. Nutritional improvements in vitamins, micronutrients, and protein 
quantity and quality are all technically within our grasp. The key is to set priorities and invest so that 
these dreams become reality. 
 
6.5 Recommendations 
Because of concerns some sectors of the public have raised about genetic engineering technology:  
The World Bank should encourage and support public dialogue about the risks and benefits of 
transgenic technology used to improve agriculture in developing countries. This dialogue 
must ensure that the voices of the people in the developing world are heard and that their 
unique needs are considered.   
 
Furthermore, given the tremendous potential of these techniques to impact the quality of life for the 
poor: 
The World Bank should provide support to innovative improvement programs that combine 
the best of conventional methods with emerging genetic engineering technology to improve 
both crops and livestock. 
 
 
7. Genetic Mapping Technology: Knowing Where the Genes Are 
7.1 Background and Prior Debate 
All genetic maps (and markers for specific traits) rely on theory developed over 80 years ago using 
morphological markers in plants and the fruit fly Drosophila. Although morphological markers were con-
venient for early studies, because they are relatively infrequent and interact with the environment they 
are now rarely used. Molecular markers, however, have no phenotypic effect, are not affected by the 
presence or absence of other genes and a large number of markers can be detected in most breeding 
populations. 
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Developed in the 1980s with reference to the human genome, genetic maps are constructed using mo-
lecular genetic markers. Such molecular approaches quickly proved to be powerful tools for studying the 
organization and behavior of plant genomes. Molecular biology has already revolutionized research in 
the life sciences, and DNA marker technology now promises to dramatically enhance the efficiency of 
plant and livestock breeding. Advances in automated technology are providing the convenience, speed, 
and level of throughput that will make it possible to offer stunning improvements to  modern breeding 
programs. Meanwhile, advances in the allied fields of sequencing and bioinformatics have come together 
to form the rapidly progressing field of functional genomics, which provides information not only about 
the location of genes but also about what they do and how they work. 
The theoretical basis for molecular marker-assisted breeding is well established and is now being rapidly 
refined, with a wide array of published examples covering most crops and animals of major economic or 
academic importance. Meanwhile, dramatic advances are being made in functional genomics, which will 
undoubtedly fuel the development of knowledge based breeding schemes. 
The primary resource of breeding programs is the genetic variability of species. Successful crop and 
livestock improvement programs must efficiently tap this variability, but traditional breeding techniques 
rely on physically identifying traits to select for (phenotypic selection). In many instances, DNA marker 
technologies offer breeders the potential of making genetic progress more cheaply, quickly, and pre-
cisely. In simple language, breeders can determine what traits a plant has by looking at its genes in-
stead of spending all the time and money needed to grow varieties by the field full. 
 
7.2 Identification of Key Issues 
Commercial plant breeding companies are moving fast to adopt these new technologies. They are in-
vesting heavily in molecular breeding because they see that it will reduce costs, increase precision, and 
make it possible to achieve new goals. In many cases, companies report returns on these investments 
within the first or second year of implementation. They are also able to make better use of their re-
sources, which adds further value. Traditionally, conventional breeders have been reluctant to use ex-
otic germplasm through backcross breeding because of complex, long-term, and unpredictable out-
comes, particularly in crops where quality traits are important market criteria. But DNA marker assisted 
approaches provide breeders with cost effective tools to rapidly unleash the vast resources held in 
germplasm collections. 
Commercial breeding companies know the value of time. Shortening crop breeding cycles can generate 
tens of millions of dollars within individual country markets. Likewise, public breeding programs, in-
creasingly driven by product-focused national government and development investor projects, are seek-
ing to maximize their product release times. Absolute cost savings, however, are not the only criteria 
that defines plant breeding strategies; increased time-efficiency throughout the breeding program may 
also be very valuable by increasing the program’s overall productivity.  
DNA marker analyses may be warranted in order to precisely fingerprint new lines for plant variety pro-
tection. In many countries, plant breeders’ rights and essential derivation clauses of patents require 
specific levels of distinctness from new varieties entered for registration.  
 
7.3 Future Trends 
Applied genomics will revolutionize the existing paradigms of plant breeding through the power of DNA 
markers. Complementary approaches that combine traditional and molecular approaches within unique 
breeding systems will be developed that will harness the capacity of a range of marker assay types, util-
izing their unique comparative advantages at different stages in the breeding system. 
 IP Strategy Today No. 2-2001 Dodds et al. 17 
Accurate germplasm diversity analysis is an intensive multi-component endeavor, one best carried out 
by the international institutions designated to act as the custodians of global germplasm collections. 
These same institutions may also be the ones that can most effectively develop complex genetic stocks 
(e.g., those that combine many different resistance genes). After their development, these breeding 
lines and their respective DNA markers should then be placed in the public domain as an integrated 
package. This will allow national breeders to rapidly and efficiently use this material in their breeding 
programs. This approach has been effectively adopted for breeding resistance to bacterial blight by na-
tional programs within the Asian Rice Biotechnology Network. 
Molecular breeding is a truly multidisciplinary endeavor where it will be increasingly difficult and expen-
sive to generate appropriate critical mass in all the essential elements required to build a functional 
team. Consequently, public-private partnerships and consortiums will be vital. Furthermore, as DNA 
marker-assisted approaches become more widely integrated into plant breeding programs, their impact 
will compound and the associated capital and operational costs will decrease—while the need for experi-
enced personnel will increase. Of course, traditional approaches will remain cost effective for many 
traits, and replicated multilocational evaluation will always be a necessary precursor to varietal release. 
 
7.4 Constraints and Opportunities 
In the future, molecular breeding will likely rely on sequence-based markers. The large-scale develop-
ment of this marker-type is highly demanding on human and capital resources. Thus, public sector insti-
tutes are best placed to carryout marker development activities. For species where there is a consider-
able amount of public domain sequence data, bioinformatics groups can cost effectively and rapidly 
identify suitable sequences for microsatellite marker development.  
Automated marker screening systems have dramatically increased data generation, which can now be 
deployed on the scale needed for modern breeding programs. In many cases, it is simply cheaper to 
contract out this type of work and use urgently needed resources elsewhere. Indeed, at least during the 
initial phase of adopting these new techniques, contracting out DNA marker screening is a cost-effective 
option for most small to medium-sized breeding programs.  
 
7.5 Recommendation 
The new tools of applied genomics are rapidly increasing our knowledge of biological systems and the 
tools to manipulate these systems. The commercial implications of these developments are fueling un-
precedented scientific progress but at the expense of free access.  
The World Bank should support initiatives in applied genomics to ensure that important ad-
vances will be made available to plant breeders in national programs and in small to me-
dium-sized companies that are supporting the development of staple crops and livestock. As 
custodian of the world’s genetic resources, the CGIAR (Consultative Group on International 
Agricultural Research) international system of agricultural research centers now has a major 
role to play in ensuring the equitable enhancement of the world’s staple food crops.  
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8. Molecular Breeding to Address Global Issues Such as Drought and Heat 
Stress 
8.1 Background and Prior Debate 
Breeders see the greatest potential for molecular markers in the area of complex traits, particularly 
those that are highly sensitive to environmental conditions. These characters are the most difficult to 
work with using phenotypic selection, and developing effective marker assisted selection systems has also 
been the most difficult for these traits. This is due to the large number of genes involved and the effects 
of genotype-by-environment (GxE). 
The principles governing the genetic basis of quantitative traits were outlined over 80 years ago; both 
quantitative and biometrical genetics evolved in the 1940s and 1950s. Since that time scientists have 
made great strides towards developing biometrical methods to assist breeders in effectively selecting 
complex traits through phenotypic evaluation. But to objectively determine how many genes influence a 
quantitative trait or what their influences are on phenotypic and genetic variation required the advent of 
DNA markers in the 1980s. Scientists were optimistic about the capacity of these new tools to simplify 
this complicated endeavor, and quantitative genetics has delivered. A new scientific heyday has been 
triggered by these recent advances in molecular biology. 
 
8.2 Identification of Key Issues 
The molecular mapping of simple traits is now a routine procedure, and attention has now shifted to the 
more practical aspects of applying these markers. In contrast, the methodology for mapping complex 
traits is still developing. Since the early 1990s, however, simulation studies have fueled rapid develop-
ments in methods for mapping complex traits (i.e., quantitative trait loci, or QTL).  
Precise phenotypic evaluation in several locations and seasons is important for measuring the effects of 
component QTL and estimating their relative contributions and stability. But developing robust QTL 
markers will likely require populations much larger than those currently used. Indeed, new high 
throughput DNA marker screening technologies will be essential for empirically testing new approaches 
to QTL mapping and for the subsequent application of marker-assisted selection systems for these 
traits. 
 
8.3 Future Trends 
Rapid developments are taking place in the model crop systems fueled by automated technologies, ad-
vanced biometrics, and functional genomics. A new knowledge based breeding paradigm is evolving in 
these systems that will facilitate advances in allied but less studied crop systems. The impact molecular 
breeding has had on maize in the past decade provides an indication of the future for all crops. At the 
beginning of the 1990’s there had been a six-fold increase in maize yields during the preceding 60 
years, but little was known about the actual genetic basis of these improvements. Today, scientists 
have not only mapped and dissected many of these underlying characters, they are also already report-
ing the manipulation of these components through the knowledge gained by the new molecular tech-
nologies. 
Modern plant breeding is a high technology business that is becoming even more complex and multifac-
eted. In this new era, successful plant breeding programs will be characterized by dynamic, holistic ap-
proaches led by functional multidisciplinary teams. A high level of synergy between team members will 
be vital for successful product-led innovation and problem solving.  
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8.4 Constraints and Opportunities 
Many important agronomic and economic traits exhibit continuous variation (e.g., heat stress, drought 
resistance, and yield). The rate-limiting factor for developing effective marker-assisted selections sys-
tems for these characters remains the confounding effects of genotype-by-environment interaction. An 
array of computational methods aimed at addressing this issue is rapidly evolving, and there are many 
publications in this area using simulation studies, but not all of them are well analyzed. Improved maps 
and more powerful computing systems may allow us to select plants that are better adapted to these 
complex situations. 
 
8.5 Recommendation 
The rapid development of molecular breeding tools for complex traits will require research projects that 
bring together large-scale multi-locational field experiments with state-of-the-art high throughput 
marker screening technologies and strong capacities in biometrics and bioinformatics. Hence: 
The World Bank should support long-term initiatives to undertake molecular breeding of crop 
and livestock species important to feeding the developing world. In this respect those CGIAR 
centers with breeding programs will continue to have a major role to play because they pos-
sess in-house capacity in all essential elements. 
 
 
9. Changing Plant Architecture: New Plants for a New Future 
9.1 Background and Prior Debate 
Humans have made tools for more than a million years, but their crop plants have evolved under the 
influence of their powers of observation, selection, and imagination for only about ten thousand years. 
Crops and humans have evolved together in a kind of symbiosis. The transformation of humans from 
hunter-gatherers to settlers led to the domestication of about 200 plants. While gathering, humans per-
haps used about 3000 plants as food. Today five major cereals, three tuber crops, plantains/bananas, 
and several legumes plus sugar cane and beet provide most of the dietary needs. While this narrow fo-
cus and intensification has helped to feed six billion people, it comes at a genetic cost. 
Domestication, for example, has included selection against seed spread so as to enable easy gathering. 
The survival of crop plants now depends on humans. This change, one of the earliest and most marked 
differences between cultivated and wild progenitors, formed the basis of agriculture. Along with reduced 
dissemination, seed size often considerably increased. Plants with larger seeds can be harvested more 
quickly and agricultural man may have selected for them. Not only the form, but also the composition of 
harvested organs has changed greatly. Toxic components prevalent in wild progenitors (e.g., yam) were 
eliminated and selection for other components of special interest increased or improved (e.g., sugar 
content or oil). In addition to dealing with above ground components, research will be further enhanced 
to address root issues such as nutrient absorption, water uptake, and production capability for root 
crops such as sweet potato. 
 
9.2 Identification of Key Issues 
The world’s amount of sustainable, cultivable land has reached its limit. Irrigating more land is a difficult 
option because of the ever-increasing demand for water from other sectors (domestic, industry). We 
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must therefore improve the yield of cultivated crops to feed the world’s constantly growing population. 
In other words, we must get more crop per drop. 
Plant architecture refers to the number, size, shape, structure, arrangement, and display of particular 
plant parts. Plant architecture per se, however, has no relation to yield except as it is associated with or 
leads to improved physiological functions. Productivity is the sum product of the photosynthetic rate and 
the leaf area (machinery). The photosynthetic rate, which is the plant’s ability to convert solar energy 
into stored energy, was once considered an avenue to increase plant productivity. But past efforts in 
this area discovered that although wild progenitors (e.g., in wheat) have high photosynthetic rates, this 
did not translate into increased stored metabolites because the other component—leaf area—became 
the limiting factor,.  
The other physiological functions that directly contribute to higher biomass are water use efficiency  
(i.e., unit of dry matter produced per unit of water used by the plant) and nutrient use efficiency. Ge-
netic variation for water use efficiency does exist within species but it is more pronounced between spe-
cies (e.g., millet vs. alfalfa) and between cultivated and wild varieties.  
 
9.3 Future Trends 
In the last 20 years only a few major genes have been used to improve yields, especially for cereal 
crops. These genes mainly control plant height and photoperiod sensitivity, both of which affect the 
harvest index.  
Biotechnology could be used to transfer some of these genes, which may be available in wild species 
that have eluded physiologists, into genotypes with high leaf area and the appropriate architecture to 
further increase yields. Furthermore, crop modeling, with data accumulated from plant physiology and 
crop protection research, may help to define ideotypes (genotypes, designed to exhibit specific charac-
ters) that can assist work of plant breeders. The characteristics required to develop improved plant pro-
totypes from such a ‘virtual breeding’ approach may be available in the gene banks for these crops or in 
those of other associated (wild) species. Otherwise, breeders could obtain novel transgenes to develop 
the required ideotype. In other words, we need to begin to design new plants in the same way we de-
sign new cars or planes, by going back to the drawing board and making bold changes in overall design 
and architecture. 
 
9.4 Major Constraints and Opportunities 
The question remains as to whether the genes that control complex physiological characters  (e.g., for 
higher photosynthetic rates) can be successfully isolated and transferred between species, especially 
from wild to cultivated gene pools. Interspecific crosses have been used in many crop species to obtain 
interesting genotypes for further improvement by breeders (e.g., in potato, banana/plantain, barley, 
tomato, and other crops). Biotechnology, however, can overcome any reproductive barriers and en-
hance the procedure in a more targeted manner with predictable results.2 Such “precision breeding” can 
be used to efficiently develop new plant types for new markets or climates. 
Of course, both water and nutrient use efficiency can be more effectively addressed by combining man-
agement options (i.e., irrigation methods, tillage, crop rotation, etc.) with a genetic approach. The ef-
fect of the environment is often so profound that the genetic gains are masked its influence. Because 
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the need for more water and nutrient efficient plants will be so great over the coming decades, both 
genetic and improved management approaches must be fully explored. 
 
9.5 Recommendation 
Given the need to feed more people on the same land area using less water and nutrients: 
Through a competitive grant framework the World Bank should encourage and support inno-
vative research (including multidisciplinary approaches) aimed at the development of spe-
cific locally adapted prototypes to maximize the yield potential of crops. This investment 
could be cost-effective by tapping the knowledge and information accumulated by the CGIAR 
and their diverse partners. 
 
 
10. Biosafety: How Safe are New Agricultural Technologies? 
10.1 Background and Prior Debate 
Given the types of issues raised in debates about the safety of genetically modified organisms, it ap-
pears that for many people the real problem with transgenic plants is that the risks associated with their 
use are not well investigated or known. But it is easier to predict gene expression in genetically modi-
fied organisms than in those developed through conventional breeding methods, and transgenes are not 
conceptually different than native genes or organisms modified by conventional technologies. Conven-
tional plant breeding has never been able to foresee or control the physiological impact of new genes. 
Much greater efforts, however, have been made to determine these impacts in regards to transgenics. 
Carefully considered procedures and regulations have been developed to evaluate the biosafety of these 
crops. The need and extent of safety evaluation, for example, can be based on a comparison of a new 
food and an analogous food. The interaction of the new gene with the environment also needs to be 
investigated because of the potential for recombinant technologies to have a greater impact on the en-
vironment than is possible with conventional technologies. The management, interpretation, and utiliza-
tion of information will be an important component of risk assessment, and will be key to determining 
the effectiveness and reliability of this technology. 
 
10.2 Identification of Key Issues 
Biosafety evaluation requires that risks, benefits, and needs be given a balanced assessment. In 1998, 
over 40 million acres of transgenic crops were grown around the globe. As these products are traded 
and pass from one country to the other, domestic regulatory regimes must be in place to ensure their 
safe use. What is safe in one country may not be safe in another because of genetic background of the 
flora. A genetically engineered potato, for example, has different safety issues in Idaho than in the 
highlands of the Andes where its wild relatives are found. Many initiatives are underway to work with 
developing countries on biosafety matters, these include efforts by the CGIAR Centers and by United 
Nations (UN) organizations such as the Food and Agricultural Organization (FAO) and the United Nations 
Industrial Organization (UNIDO). Other biotechnology providers such as the International Service for 
the Acquisition of Agri-Biotech Applications (ISAAA), the Agricultural Biotechnology for Sustainable Pro-
ductivity (ABSP), and others are also providing training in this area. 
 
 IP Strategy Today No. 2-2001 Dodds et al. 22 
10.3 Future Trends 
As with any new and evolving technology, due caution must be exercised until the products of the tech-
nology are proven safe and are deregulated. Transgenic technology is like any other technology in this 
respect, and the emphasis of biosafety regulations should therefore be on the product rather than on 
the process.  
Under the auspices of National Academy of Sciences of the USA, a working group of policy makers and 
scientists from six countries has recommended that a careful analysis of safety issues is required before 
the development of  a commercial product using biotechnology—as is the case, they note, with the de-
velopment of any new technology. Specifically, it must be shown that if the potential impact of a trans-
genic plant is not neutral or innocuous, it is preferable to the impact of the conventional agricultural 
technologies that it is designed to replace. 
 
10.4 Major Constraints and Opportunities 
As is the case with conventional plant breeding, research on transgenic crops aims to selectively alter 
and add or remove a character of choice in a crop plant with reference to regional needs and opportuni-
ties. Biotechnology offers the knowledge and tools to breed crops faster, with more precision, and with 
more genetic sources, but the promise of this technology to sustainably increase crop yields and pro-
ductivity has been dimmed by concerns about the safety of transgenic organisms and their impact on 
the environment.. In some developed countries, public interest and environmental groups have raised 
concerns about the possible effects—conceived of in the broadest of terms—that transgenic crops could 
have on non-target organisms. In the developing world, such concerns have given rise to fear because 
of a lack of information. In response to these concerns, a biosafety working group has been formed by 
FAO, United Nations Environment Program (UNEP), UNIDO, and WHO, and guidelines for the handling 
and release of genetically modified organisms have been published.  
 
10.5 Recommendation 
Given that a number of other international organizations are already actively working with developing 
countries in the area of biosafety:  
The World Bank should support the development of appropriate biosafety guidelines in the 
developing world by collaborating with other organizations engaged in similar efforts. 
 
 
11. Food Safety: It Is Safe to Grow, but is It Safe to Eat? 
11.1 Background and Prior Debate 
Genetically improved foods are not intrinsically good or bad for humans. Their health effects depend on 
their specific content. Thus the risks and opportunities associated with genetically improved foods 
should be integrated into a country’s general food safety regulations. Regulatory systems are also 
needed to govern food safety and assess any environmental risks, monitor compliance, and enforce 
regulations. Regulatory arrangements should be country-specific and reflect relevant risk factors. It may 
also be necessary to label transgenic foods, not only for cultural and religious reasons but also because 
consumers may want to know what their food contains and how it was produced. The public sector must 
design and enforce safety standards; it is one of the fundamental roles and responsibilities of govern-
ments. 
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Recent studies conducted by the National Academy of Sciences of USA on the safety of  genetically 
modified organisms concluded that “crops modified by molecular and cellular methods should pose risks 
no different from those modified by classical genetic methods for similar traits.” The focus of science 
based analyses should be on the product and not the process, and so the steps used to conduct a risk 
assessment should be the same whether the risk assessment is performed by a government regulatory 
agency, an institutional variety release committee, or a private organization. Furthermore, both the 
safety assessment process and its conclusions should be public. 
Several traditional detection methods have been proposed to detect recombinant allergens in transgenic 
foods. These methods are well established, specific, sensitive, and reproducible. They have already 
been effectively used to investigate recombinant food proteins in transgenic food products for their po-
tential allergenicity.  
A good example of the importance and effectiveness of such regulatory mechanisms was the detection 
of an allergen in a transgenic soybean. The allergen originated from Brazil nuts, some of the genes of 
which were expressed in soybeans to increase their sulfur content. But the modified soybeans also 
bound IgE from Brazil nut-sensitive individuals and were identified as a major Brazil nut allergen. This 
demonstrated that testing for allergens in new products when proteins are transferred from sources that 
contain known allergenic material will work. It also indicates that a safer approach would be to avoid 
the transfer of genes encoding for known food allergens. Genes transferred from sources known to be 
allergenic should be assumed to encode for an allergen, until proven otherwise.  
 
11.3 Future Trends 
Some discussions on transgenic crops place undue stress on risk assessment at the expense of any con-
sideration of their potential advantages. Furthermore, although food allergies are a high priority in in-
dustrial countries, in countries with emerging economies they are a lower priority than nutrition. In any 
case, the increased productivity benefits of genetically modified foods may far outweigh any potential 
risk of allergic reactions. With reasonable biosafety regulations, this can be done with little or no risk to 
human health and the environment. 
If they are not made accountable to the findings of science, the unnecessary escalation of increasingly 
stringent biosafety regulations regarding transgenic plants or food—in the absence of any scientifically 
proven generic risk—may prevent the application of transgenic research to sustainable staple food pro-
duction or poverty alleviation. The global community must keep its sights set on the goal of assuring 
food for all. We cannot afford to be elitist luddites about any aspect of a possible solution, including ag-
ricultural biotechnology. 
 
11.4 Major Constraints and Opportunities 
Allergies to foods are generally a significant public health concern throughout the world. About 2% of 
adults and 4% to 6% of children suffer from food allergies, defined as adverse immunologically medi-
ated reactions to antigenic molecules present in foods. Moreover, in the case of transgenic plants, since 
the transgenes code for proteins that ordinarily may not be present in the particular non-transgenic 
plants, there is particular concern about the potential allerginicity or toxicity of these new varieties to 
both human and livestock health.  
Of course, genetic engineering approaches can be used to combat food allergies. Agricultural biotech-
nology has so far been used to transfer such traits as insect and virus resistance, herbicide tolerance, 
and changes in composition or nutritional content. The amount of protein expressed by the introduced 
genes is usually small and, in some cases, inactivation of a native gene results in the absence of a spe-
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cific protein yields the desired trait (e.g., the tomato genetically engineered to delay ripening). This 
technology has the potential to reduce or eliminate the expression of major allergens. 
 
11.5 Recommendation 
Given public concerns and the government’s fundamental role in setting food health policies: 
The World Bank should encourage and ensure science-based debate and decision-making 
about food health matters. The benefits of technological change, the possible risks of this 
change, and the consequences of no change should be addressed. 
 
 
12. Bioethics 
12.1 Background and Prior Debate 
Irrespective of the advances in plant biotechnology and its potential for crop improvement, the ethical 
dilemmas associated with the incorporation of transgenic crops into farming systems have divided both 
public and private researchers worldwide. This was not unexpected because the adoption of any new 
technology has rightly always been accompanied by careful scrutiny. An outright ban of transgenic 
crops, however, is neither a scientifically or economically sound option because their potential benefits 
(e.g., resistant or tolerant crops to abiotic and biotic stresses) also need to be carefully analyzed. The 
value of such traits should not be arbitrarily withheld from the public, especially the poor citizens of de-
veloping countries. 
 
12.2 Identification of Key Issues 
Banning biotechnology, particularly genetically modified organisms (GMOs), is a short sighted, narrow 
approach to a consideration of the technology’s potential benefits—particularly in regards to the envi-
ronment. Crops that eliminate or reduce the amount of polluting agro-chemicals in farming systems 
must be welcome by farmers and consumers. Indeed, the general public should see biotechnology as a 
tool for scientific crop improvement that is safer than many technologies already in use. 
In the ongoing debate on globalibation and privatization, some groups see the protection of plant varie-
ties and the use of contract mechanisms on the international scale as "ethical" agenda items. 
The private sector wants to use biotechnology to accelerate its growth. Its search for profit, as in any 
other business, attracts investment in the industry, which also looks for new ways of protecting these 
investments through intellectual property rights, especially if biotechnology applications are used for 
accelerating the genetic enhancement of crops.  
The private seed sector has shown that plant variety protection (PVP) encourages and ensures a return 
on research investments. PVP, as indicated by agri-business managers, helps to facilitate the transfer of 
technology and knowledge, providing encouragement and assurance for plant breeders to introduce 
their best varieties for production and propagation. In short, the private seed sector holds that any kind 
of plant variety protection would attract new and improved genetic material and technology, thereby 
enhancing the quality and yield of breeding materials. As a consequence of the introduction of intellec-
tual property protection, material transfer agreement (MTA) has become a routine document for ex-
change of genetic material.  
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12.3 Future Trends 
Public awareness and education about how biotechnology can improve crops may foster a proper dis-
cussion of its risks and benefits for farming systems and for biodiversity. The debate about crop bio-
technology currently suffers from the loud exponents of non-scientific partisan views, a general lack of 
reference to scientific data, an exclusive focus on the uncertainty of potential risks, and ignorance about 
the basic contexts and processes of the technology. The public needs to hear the words of Nobel Peace 
Prize winner Norman Borlaug, who in a recent letter to a British newspaper describes the genetic modi-
fication of crops as a "progressive harnessing of the forces of nature to the benefit of feeding the human 
race. It is not a replacement to conventional breeding but rather a complementary research tool to 
identify desirable traits from remotely related taxonomic groups and transfer them more quickly and 
precisely into high yielding, high quality crop species." 
The issue of releasing genetically modified plants (GMP) into the farming system has become particu-
larly sensitive in Europe despite the widespread cultivation of such crops in North America and else-
where. Scientists must realize that the general public is concerned that an un-cautious approach to the 
manipulation and cultivation of transgenic crops may affect biodiversity and its sustainable utilization in 
the farming system, (e.g., loss of variability and viability). They should make efforts to show how 
transgenic crops contribute to the protection of the environment, particularly the fostering of biodiver-
sity. 
 
12.4 Major Constraints and Opportunities 
Collective approval may lead to new partnerships, cooperation, or joint ventures in research and devel-
opment between scientists in the public and private sectors that will benefit farmers and consumers 
with profits and high quality products, respectively. Any potential risk in human development associated 
with biotechnology applications in agriculture should be resolved in a transparent, rational, and democ-
ratic fashion. The public needs to be able to trust the balanced, science-based safety regulations arrived 
at by lawmakers after listening to the views of scientists, producers, and consumers. 
 
12.5 Recommendations 
Given the concerns associated with the development and deployment of genetically engineered organ-
isms: 
The World Bank (both management and staff) should be aware and sensitive to the issues 
surrounding GMO’s and other biotechnology applications. The World Bank should encourage 
scientific transparency; this will be the best tool to convince people about the advantages of 
transgenic crops and other biotechnology applications.  
 
 
13. The Public Sector and International Public Good 
13.1 Background and Prior Debate 
The bulk of scientific knowledge is in the public domain and forms a body of International Public Goods.  
It should be remembered that after the limited exclusionary period, proprietary technology enters the 
public domain.  Furthermore, although the content of a patent is "owned" by the inventor it is fully dis-
closed as a condition of granting the patent. 
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At the end of a patent’s statutory life, the exclusive right is gone and the material is public knowledge. 
This approach in the pharmaceutical area has led to the growth of the so-called “generics” market. 
Products whose patent has expired are then manufactured by a variety of companies for direct sale in 
the marketplace. 
In the case of agriculture, up until the last decade most information and materials were in the public 
domain. The Green Revolution was based in large part on materials and knowledge flowing from Univer-
sities and governmental research and breeding programs straight to farmers around the world. This was 
possible because before the 1980 Bayh/Dole act all such information was in the public domain. 
Over the last decade, however, a substantial shift has occurred in the ability of public organizations to 
seek proprietary protection. Indeed, most governmental research laboratories and large universities in 
the industrial world now have their own IP offices to patent inventions from their research, including 
that sponsored by governmental agencies.  
This “privatization” of public sector research has blurred the line between international bodies that are 
accessing research materials and multinational corporations. It is essentially no different to negotiate a 
license agreement with a major university than with a multinational.  
 
13.2 Identification of Key Issues 
Of all the areas under consideration in this report none is so complex or sensitive as determining the 
ownership of ideas and materials. There are strong opposing schools of thought on these matters, both 
of which offer rational and convincing arguments. A number of questions need to be addressed; our po-
sition on these matters is as follows: 
1. Is the current “privatization” of public goods healthy? In general terms YES, so long as private 
ownership is balanced with access rights for scientists to continue further research. This temporary 
ownership also serves as a substantial stimulus to private research investment. The result of such 
investment has been powerful in information technology and pharmaceuticals; we would like to see 
the same growth in agricultural research. There are also usually public use provisions when the re-
search has been done through public funds. 
2. Are we looking at the availability of information, or its ownership? These are different, but related 
matters. To the scientist, the important issue is access to information; for product development, 
ownership is critical. In those crops where market forces are not directly applicable, other more in-
novative license agreements or waivers will be needed. 
3. Is the privatization of these systems economic? In simple terms, if it is not economic then it will fail 
under privatization. The question then is whether the government still attaches sufficient strategic 
priority that it wishes to keep funding it from internal revenues. 
4. How much is the trend driven by a desire to gain bargaining power? To some extent, owning some 
technology allows you to “trade” your IP for their IP. However, care should be exercised to ensure 
that there is truly something of value to trade. It is a viable alternative to truly keep all public in-
ventions in the public domain and then seek access to alternative mechanisms. 
5. How much is public access rather than ownership the issue? To the scientist, very much so. The 
ability to use the information for research purposes is critical to the progress of any research 
agenda. Ownership becomes an issue when the technology is deployed or commercialized. The 
ISAAA freedom to operate study on GoldenRice is a good example of the challenges that can be 
faced in moving from the research phase to potential product deployment. 
6. Are international public goods something unique? Clearly YES. There are technologies, problems, 
and opportunities that spread beyond national boundaries. The whole set of issues surrounding ge-
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netic resources, global warming effects, and many disease and pest control matters are truly inter-
national in scope and need concerted international efforts.  
7. Is agriculture a unique circumstance that can be afforded some exemption? This is a truly difficult 
question to answer. While our existence on the planet depends on agricultural production, the same 
arguments can be made in other sectors such as health and energy.It could legitimately be argued, 
however, that staple food crops in the developing world are worthy of special treatment; likewise, 
crops and livestock with strong local but little international commodity focus should be treated 
somewhat differently. One way to resolve this may be to allow inventions a shorter time period in 
the proprietary domain before becoming public goods. 
 
13.3 Future Trends 
If the human genome program is the model for future research, then clearly more and more discoveries 
will by privately owned. The drive to obtain returns on massive private investments will likely mean that 
research will proceed more rapidly in the private than in the public sector. The human genome project, 
it will be recalled, began as a public research plan scheduled to take 10 to 15 years, yet a private sector 
effort, headed in large part by ex-public research employees, did it in 2 years with only 10% of the 
staffing. This has allowed 10+ years of research dollars in the public sector to be redirected to other 
areas. 
There is also a trend towards data overload. The volume of information and its management will be a 
major issue. As an example of this the US Patent & Trademark Office is reviewing how it can maintain 
its patent sequence databases given the explosive growth of patent filings in this area. As the human 
genome project also revealed, there will be a trend to license DATA rather than materials. The capital of 
tomorrow will be data not goods—after all, we are in a knowledge economy. 
 
13.4 Major Constraints and Opportunities 
Constraints: 
A major constraint for developing counties will be a lack of expertise about the computing and database 
skills and infrastructure needed to access the huge amount of public data that will be available. 
Furthermore, as more data becomes proprietary, the skills needed to negotiate equitable license 
agreements--both with the private sector and with the new public sector—will be very important. In 
general, developing countries do have such experience in negotiating license agreements. 
 
Opportunities: 
New technology offers developing countries access to information in a revolutionary way. The poorly 
stocked libraries of the developing world can be upgraded to the highest possible standards with mini-
mal investments in databases and infrastructure. In short books are gone, all countries have equal ac-
cess to data. What an opportunity! Investments in essential library technologies will have enormous 
returns and should be given a high priority. 
 
13.5 Recommendations 
Given the tremendous opportunities that exist to leverage publicly available data: 
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The World Bank should increase spending on infrastructure and human capacity building in 
regards to database management and information sorting and dissemination. 
Through support to the CGIAR, the World Bank can take steps to improve database manage-
ment and ownership for many staple food commodities. The World Bank can foster a genome 
network for the developing world to access databases through the CGIAR and its partners. 
 
 
14. Public Sector/Private Sector Partnerships: The Need for their Visionary 
Expansion and Diversity 
14.1 Background and Prior Debate 
Over the last decade a number of interesting models have enhanced and fostered interaction and coop-
eration between the public and the private sectors. Each sector brings a unique set of advantages to the 
relationship, creating a powerful synergy based upon their complementary strengths. The basis for the 
success of these relationships is complex, involving trust, mutual understanding, respect for goals and 
aims, and a clear set of institutional objectives. The issues of trust and understanding cannot be under-
estimated.  
In the international agricultural biotechnology area, several programs have been active over the last 
decade in promoting public/private interactions, these include ABSP, a USAID funded program, ISAAA, a 
not-for-profit program hosted by Cornell University, and the Intermediary Biotechnology Service (IBS), 
managed at the International Service for National Agricultural Research (ISNAR), one of the CGIAR re-
search centers. The common thread linking these organizations is the integrated nature of their pro-
grams, which include not only research but also regulatory and IP matters. This integration of science, 
policy, and regulatory affairs allows for maximum utilization of the comparative advantages of the pub-
lic and private sectors. 
 
14.2 Identification of Key Issues 
As indicated above, building productive relationships between these sectors is complex and takes time. 
Given the sovereignty issues in regards to IP law and regulations, there are additional complications to 
these arrangements at the international level. Indeed, the key issues that underpin these agreements 
will need to be continually reviewed and improved. Yet as the examples below indicate, progress is al-
ready being made:  
1. How to build mutual trust and confidence, particularly in regards to confidential information? This is 
a lengthy process. As a result of a workshop held by USAID in Washington, the ABSP project was 
started, which brings together the public and private sectors in agricultural partnerships. It has bro-
kered a wide range of partnerships with small and large companies, universities, and governmental 
research organizations in both the US and various developing countries. These partnerships include: 
a. DNAP, a New Jersey small cap research company, and private sector producers in Indonesia and 
Costa Rica. 
b. The Egyptian Agricultural Genetic Engineering Research Institute and Pioneer Seeds. 
c. Monsanto Company and the Kenyan Agricultural Research Institute.  
d. Zeneca Seeds and the Indonesian Food Crops Research Institute. 
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2. Liability concerns are an increasing concern. When a company donates its technology to a develop-
ment project it foregoes income but is not absolved of liability. If companies are to be encouraged 
to “donate” technologies then there must be a mechanism to deal with their liability exposure. 
3. There is a need to identify common processes and methods. To make all of these arrangements on 
a one-on-one basis is inefficient and stifles expansion. We believe that the World Bank, working 
with and through other organizations, can do much to create a framework and universal templates 
for these types of technology transfer processes. 
4. The issue of confidentiality is critical to the building of the trust and confidence. This is true not only 
for IP but also in regulatory matters. There is a need for greater understanding of the importance of 
confidentiality to the private sector.  Clearly, if information is allwed to leak through poor steward-
ship then the owner will be damaged and will lack the confidence to share additional new confiden-
tial information. 
 
14.3 Future Trends 
Globalization of trade and research will also result in more examples of multinationals linking up with 
host governmental organizations. The regulatory environment will also evolve as the harmonization of 
health and environmental standards continues through the process of trade globalization. 
 
14.4 Major Constraints and Opportunities 
Constraints: 
There still exists the possibility of public backlash against the privatization and globalization of research, 
particularly in relation to health and safety concerns. Developing countries have the right, however, to 
set their own risk and benefit parameters. 
Anti-trust actions now common in the software industry may begin to become issues in agriculture and 
health, particularly in relation to biotechnology.  
 
Opportunities: 
Knowledge is the lifeblood of research, whether in the public or the private sector. The potential benefits 
to all sectors of society from greater knowledge sharing are tremendous. The human genome project is 
a good example of how it is possible to take ownership rights while still broadly sharing the information 
for research. More efforts are needed in this area. 
The opportunities to create powerfully synergistic partnerships are abundant; they require only our 
careful planning and commitment. Their potential benefits are particularly evident in cases where pri-
vate sector technology has impacted a major commodity or disease which can then be used by the pub-
lic sector for orphan crops or for diseases where the private sector is unable to see returns from a 
purely economic standpoint. 
The public sector, however, is still the primary producer of the raw material of innovation: skilled peo-
ple! The role that education plays in terms of building scientific, legal, and entrepreneurial skills cannot 
and should not be underestimated. 
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14.5 Recommendations 
Given the globalization of agricultural research companies and the current shift in research resources 
from the public to the private sector: 
The World Bank should develop additional fora that will bring together the public and private 
sector in an enabling environment that will allow for the building of mutual trust and a dia-
logue on research and regulatory issues. 
The World Bank should continue to support programs to enhance the skills of scientists, law-
yers, and policy makers in these new areas of science and law. Skills in science and negotia-
tion are important components for fair partnership arrangements. 
 
While proprietary technology will use market forces to drive license agreements in market economies 
and sectors, provision must be made for those sectors of society that are left behind. Therefore: 
The World Bank should try to identify areas where private sector proprietary technology de-
veloped for one purpose may be able to play humanitarian purposes in other areas, such as 
orphan crops or diseases prevalent in the developing world. 
 
 
15. IPR and Animal Science 
15.1 Background and Prior Debate 
The impact of biotechnology on the public has been dramatic in the area of animal science. The cloned 
sheep “Dolly” propelled debate on a wide range of technological, ethical, and religious matters, and fur-
ther research—which has now led to research level cloned production of pigs and cattle—will certainly 
keep this debate front and center. 
Animal biotechnology research has the benefit of gaining substantial knowledge from overspill in the 
human genomics and health area, which has the disadvantage of competing for research talent and in-
vestments in those areas. There is clearly a huge degree of genetic similarity between humans and 
other animal species. The identification of disease resistance genes in one species will greatly assist the 
search for disease resistance in other species. 
The human genome project has led to the production of a wealth of information that clearly will have 
added value in the areas of animal science. Likewise, development of vaccines and other treatments for 
diseases will benefit animal science researchers. 
Animal science is also having difficult times in regards to public relations and perceptions in recent 
years. “Mad cow disease” has swayed public perception in animal science away from high technology, 
particularly the application of biotechnology, towards organic production mechanisms.  The use of the 
growth hormone BST in milk production has raised human health questions. The potential tragedy of 
the PR scenario is that while increased milk production may be an economic problem for some industrial 
countries it is potentially a major benefit for many developing countries. The use of BST to increase milk 
has tremendous potential benefit to the growing population of the developing world, where milk is in 
scarce supply but is an excellent nutritional source, particularly for women and children. Biotechnology 
also has tremendous potential to produce effective vaccines against a wide range of animal diseases, 
many of which are important in the tropics. 
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15.2 Identification of Key Issues 
Some of the issues in animal science are common with to their counterparts in the plant sciences, but 
some are unique. The critical issues and some examples of how to address them are: 
1. How to build on the human genome project for animal science? In the short term, this is where the 
most rapid advances in genomics research may be made. The International Livestock Research In-
stitute (ILRI) of the CGIAR is already working with the Institute of Genomic Research (a not-for-
profit entity related to Celera Genomics) to sequence animal parasite genomes. This will lead to the 
production of new vaccines to address tropical animal diseases. Again, a critical component here will 
be access by research scientists to publicly available databanks. As a provider of international public 
goods, the CGIAR has a unique role to play, especially in disease control, where parasites and pests 
hold no respect for international geographic boundaries. 
2. What about the ethical issues related to animal cloning? Of course, this is worthy of an entire trea-
tise in its own rights. If pork genes are put into chicken can Muslims eat it? If animal genes are put 
into plants can vegetarians eat them? If a chromosome is made synthetically and inserted into an 
animal is this ethical? There are no simple answers to these questions. The answers to these reli-
gious and ethical dilemmas must come from those skilled in those areas. The key technical issue, in 
the view of these authors, is the public’s right to know and choose. The mechanism for this may be 
through labeling schemes, but more support to resolve these matters is needed. 
3. What about the biosafety aspects of animal science? Clearly there are animal diseases that can be 
passed to humans. Again, the concerns on mad cow disease underline this matter. The biosafety is-
sues in relation to research studies and the use of research containment for animal science again 
are highly complex. More research is needed in this area, especially where there is any perception 
that the disease can be transmitted to humans. ILRI is a unique organization to guide and advise in 
this area. 
4. Which animals and diseases should take priority? This is a national priority setting exercise. It 
should balance technical capabilities against needs and economic realities. There is some rationale 
for first studying those pests and diseases that cross-national barriers and cause regional health 
problems. 
 
15.3 Future Trends 
The human genome infrastructure will soon seek new target organisms to sequence, and animal science 
is the next logical field. The same issues discussed above will arise again: what will be the impact not 
only on database and knowledge development? Who will own this information? 
Vaccine development will grow rapidly as new recombinant technologies allow custom design of vac-
cines against major pests and diseases. The heat stability of these vaccines should also be a major plus 
for the developing world. 
Greater understanding of animal pathogens should also greatly increase the impact that biotechnology 
will have on animal health and productivity. 
 
15.4 Major Constraints and Opportunities 
Constraints: 
The ethical issues associated with animal science are more complex and more culturally linked than is 
the case with plant technologies. 
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The economic impact of diseases has global importance. The costs of vaccine production and distribu-
tion can be recuperated for high value farming systems, but how are these techniques to be economi-
cally applied to resource poor small farmers? The arguments here are very similar to those for human 
tropical diseases. We have not solved this for malaria, so when will we tackle animal disease? We be-
lieve, however, that there is some light at the end of this tunnel. The Institute of Genomics Research 
(TIGR) is discussing a malaria vaccine trial for 2002. 
The biosafety and human health aspects of recombinant animal technologies are complex and costly. 
Can we find effective, low cost methods and regulatory frameworks that will allow the potential benefits 
of this technology to flow? These authors believe Yes. The potential impact on milk and animal meat 
production in the developing world is to great for us not to act. 
 
Opportunities: 
The revolution in human genomics can and is revolutionizing animal science. The synergy between hu-
man research and animal science offers unique opportunities for common platforms and reduced cost. 
Once we identify genes in the human genome with specific characteristics, we can almost certainly ap-
ply the same knowledge in animal science. 
Increased economic development usually leads to higher consumption of animal proteins. This increased 
economic growth should spill over into increased investment in animal science research and develop-
ment. 
 
15.5 Recommendations 
Given the important economic and nutritional roles that livestock play in rural communities: 
The World Bank should support special international studies to review the human health im-
plications of genetically modified animal products. Given the costs associated with these 
studies, harmonization and cross acceptance of data is very important. 
The World Bank should continue to study the impact of biotechnology and of quarantines on 
the trade of animal products. There is a special need to study these impacts as they relate to 
tropical diseases in Africa. 
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